E. Ginter and V. Simko, Type 2 diabetes mellitus, pandemic in 21st century, Adv Exp Med Biol, vol.771, pp.42-50, 2012.

A. M. Johnson and J. M. Olefsky, The origins and drivers of insulin resistance, Cell, vol.152, pp.673-84, 2013.

P. P. Toth, Insulin resistance, small LDL particles, and risk for atherosclerotic disease, Curr Vasc Pharmacol, vol.12, pp.653-660, 2014.

A. Salminen, M. Lehtonen, T. Paimela, and K. Kaarniranta, Celastrol: Molecular targets of thunder god vine, Biochem Biophys Res Commun, vol.394, pp.439-481, 2010.

A. C. Allison, R. Cacabelos, V. R. Lombardi, X. A. Alvarez, and C. Vigo, Celastrol, a potent antioxidant and anti-inflammatory drug, as a possible treatment for Alzheimer's disease, Prog Neuropsychopharmacol Biol Psychiatry, vol.25, pp.1341-57, 2001.

R. Kannaiyan, M. K. Shanmugam, and G. Sethi, Molecular targets of celastrol derived from thunder of god vine: Potential role in the treatment of inflammatory disorders and cancer, Cancer Lett, vol.303, pp.9-20, 2011.

B. Peng, L. Xu, and F. Cao, HSP90 inhibitor, celastrol, arrests human monocytic leukemia cell U937 at G0/G1 in thiol-containing agents reversible way, Mol Cancer, vol.9, p.79, 2010.
URL : https://hal.archives-ouvertes.fr/inserm-00668221

S. H. Venkatesha, B. Astry, S. M. Nanjundaiah, H. Yu, and K. D. Moudgil, Suppression of autoimmune arthritis by celastrus-derived celastrol through modulation of proinflammatory chemokines, Bioorg Med Chem, vol.20, pp.5229-5263, 2012.

D. H. Zhang, A. Marconi, and L. M. Xu, Tripterine inhibits the expression of adhesion molecules in activated endothelial cells, J Leukoc Biol, vol.80, pp.309-328, 2006.
URL : https://hal.archives-ouvertes.fr/inserm-00180304

X. Yu, W. Tao, F. Jiang, C. Li, J. Lin et al., Celastrol attenuates hypertensioninduced inflammation and oxidative stress in vascular smooth muscle cells via induction of heme oxygenase-1, Am J Hypertens, vol.23, pp.895-903, 2010.

J. E. Kim, M. H. Lee, and D. H. Nam, Celastrol, an NF-?B inhibitor, improves insulin resistance and attenuates renal injury in db/db mice, PLoS ONE, vol.8, p.62068, 2013.

J. S. Bogan, Regulation of glucose transporter translocation in health and diabetes, Annu Rev Biochem, vol.81, pp.507-539, 2012.

J. W. Hunnicutt, R. W. Hardy, J. Williford, and J. M. Mcdonald, Saturated fatty acidinduced insulin resistance in rat adipocytes, Diabetes, vol.43, pp.540-545, 1994.

H. Lei, F. Lu, and H. Dong, Genistein reverses free fatty acid-induced insulin resistance in HepG2 hepatocytes through targeting JNK, J Huazhong Univ Sci Technol Med Sci, vol.31, pp.185-194, 2011.

S. L. Fernandez-valverde, R. J. Taft, and J. S. Mattick, MicroRNAs in ?-cell biology, insulin resistance, diabetes and its complications, Diabetes, vol.60, pp.1825-1856, 2011.

M. D. Williams and G. M. Mitchell, MicroRNAs in insulin resistance and obesity, Exp Diabetes Res, vol.2012, p.484696, 2012.

K. W. Chang, T. H. Chu, and N. R. Gong, miR-370 modulates insulin receptor substrate-1 expression and inhibits the tumor phenotypes of oral carcinoma, Oral Dis, vol.19, pp.611-620, 2013.

T. Horie, K. Ono, and H. Nishi, MicroRNA-133 regulates the expression of GLUT4 by targeting KLF15 and is involved in metabolic control in cardiac myocytes, Biochem Biophys Res Commun, vol.389, pp.315-335, 2009.

Y. Hua, Y. Zhang, and J. Ren, IGF-1 deficiency resists cardiac hypertrophy and myocardial contractile dysfunction: Role of microRNA-1 and microRNA-133a, J Cell Mol Med, vol.16, pp.83-95, 2012.

H. J. Jeong, S. Y. Park, W. M. Yang, and W. Lee, The induction of miR-96 by mitochondrial dysfunction causes impaired glycogen synthesis through translational repression of IRS-1 in SK-Hep1 cells, Biochem Biophys Res Commun, vol.434, pp.503-511, 2013.

L. Rocca, G. Badin, M. Shi, and B. , Mechanism of growth inhibition by MicroRNA 145: The role of the IGF-I receptor signaling pathway, J Cell Physiol, vol.220, pp.485-91, 2009.

H. Lu, R. J. Buchan, and S. A. Cook, MicroRNA-223 regulates Glut4 expression and cardiomyocyte glucose metabolism, Cardiovasc Res, vol.86, pp.410-430, 2010.

K. Rai, N. Takigawa, and S. Ito, Liposomal delivery of microRNA-7-expressing plasmid overcomes epidermal growth factor receptor tyrosine kinase inhibitorresistance in lung cancer cells, Mol Cancer Ther, vol.10, pp.1720-1727, 2011.

S. Raychaudhuri, MicroRNAs overexpressed in growth-restricted rat skeletal muscles regulate the glucose transport in cell culture targeting central TGF-? factor SMAD4, PLoS ONE, vol.7, p.34596, 2012.

J. Zhang, Y. Y. Du, and Y. F. Lin, The cell growth suppressor, mir-126, targets IRS-1, Biochem Biophys Res Commun, vol.377, pp.136-176, 2008.

S. P. Cousin, S. R. Hügl, C. E. Wrede, H. Kajio, M. G. Myers et al., Free fatty acidinduced inhibition of glucose and insulin-like growth factor I-induced deoxyribonucleic acid synthesis in the pancreatic beta-cell line INS-1, Endocrinology, vol.142, pp.229-269, 2001.

A. V. , The functions of animal microRNAs, Nature, vol.431, pp.350-355, 2004.

Y. Zhang, L. Yang, and Y. F. Gao, MicroRNA-106b induces mitochondrial dysfunction and insulin resistance in C2C12 myotubes by targeting mitofusin-2, Mol Cell Endocrinol, vol.381, pp.230-270, 2013.

D. Leto and A. R. Saltiel, Regulation of glucose transport by insulin: Traffic control of GLUT4, Nat Rev Mol Cell Biol, vol.13, pp.383-96, 2012.

K. D. Copps and M. F. White, Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2, Diabetologia, vol.55, pp.2565-82, 2012.

E. R. Gilbert and D. Liu, Epigenetics: The missing link to understanding ?-cell dysfunction in the pathogenesis of type 2 diabetes, Epigenetics, vol.7, pp.841-52, 2012.

V. Rottiers and A. M. Näär, MicroRNAs in metabolism and metabolic disorders, Nat Rev Mol Cell Biol, vol.13, pp.239-50, 2012.

S. Shantikumar, A. Caporali, and C. Emanueli, Role of microRNAs in diabetes and its cardiovascular complications, Cardiovasc Res, vol.93, pp.583-93, 2012.

H. Li, Y. Li, D. Liu, H. Sun, and J. Liu, miR-224 is critical for celastrol-induced inhibition of migration and invasion of hepatocellular carcinoma cells, Cell Physiol Biochem, vol.32, pp.448-58, 2013.

M. Sha, J. Ye, L. X. Zhang, Z. Y. Luan, and Y. B. Chen, Celastrol induces apoptosis of gastric cancer cells by miR-146a inhibition of NF-?B activity, Cancer Cell Int, vol.13, p.50, 2013.

G. Chadalapaka, I. Jutooru, and S. Safe, Celastrol decreases specificity proteins (Sp) and fibroblast growth factor receptor-3 (FGFR3) in bladder cancer cells, Carcinogenesis, vol.33, pp.886-94, 2012.

R. Kannaiyan, H. S. Hay, and P. Rajendran, Celastrol inhibits proliferation and induces chemosensitization through down-regulation of NF-?B and STAT3 regulated gene products in multiple myeloma cells, Br J Pharmacol, vol.164, pp.1506-1527, 2011.

J. H. Lee, T. H. Koo, and H. Yoon, Inhibition of NF-kappa B activation through targeting I kappa B kinase by celastrol, a quinone methide triterpenoid, Biochem Pharmacol, vol.72, pp.1311-1332, 2006.

H. Hieronymus, J. Lamb, and K. N. Ross, Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators, Cancer Cell, vol.10, pp.321-351, 2006.

L. Huang, Z. Zhang, and S. Zhang, Inhibitory action of celastrol on hypoxiamediated angiogenesis and metastasis via the HIF-1? pathway, Int J Mol Med, vol.27, pp.407-422, 2011.

S. Y. Jang, S. W. Jang, and J. Ko, Celastrol inhibits the growth of estrogen positive human breast cancer cells through modulation of estrogen receptor ?, Cancer Lett, vol.300, pp.57-65, 2011.

V. R. Yadav, B. Sung, and S. Prasad, Celastrol suppresses invasion of colon and pancreatic cancer cells through the downregulation of expression of CXCR4 chemokine receptor, J Mol Med, vol.88, pp.1243-53, 2010.